CY1112087T1 - Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα - Google Patents

Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα

Info

Publication number
CY1112087T1
CY1112087T1 CY20111101154T CY111101154T CY1112087T1 CY 1112087 T1 CY1112087 T1 CY 1112087T1 CY 20111101154 T CY20111101154 T CY 20111101154T CY 111101154 T CY111101154 T CY 111101154T CY 1112087 T1 CY1112087 T1 CY 1112087T1
Authority
CY
Cyprus
Prior art keywords
products
rythromycin
procedure
application
new
Prior art date
Application number
CY20111101154T
Other languages
Greek (el)
English (en)
Inventor
Alexis Denis
Giuseppe Gigliotti
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9808795A external-priority patent/FR2780977B1/fr
Priority claimed from FR9905245A external-priority patent/FR2792637B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of CY1112087T1 publication Critical patent/CY1112087T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CY20111101154T 1998-07-09 2011-11-24 Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα CY1112087T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9808795A FR2780977B1 (fr) 1998-07-09 1998-07-09 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR9905245A FR2792637B1 (fr) 1999-04-26 1999-04-26 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP99401706A EP0974598B1 (fr) 1998-07-09 1999-07-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments

Publications (1)

Publication Number Publication Date
CY1112087T1 true CY1112087T1 (el) 2015-11-04

Family

ID=26234434

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111101154T CY1112087T1 (el) 1998-07-09 2011-11-24 Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα

Country Status (8)

Country Link
US (1) US6433151B1 (https=)
EP (1) EP0974598B1 (https=)
JP (1) JP4573925B2 (https=)
AT (1) ATE521619T1 (https=)
CY (1) CY1112087T1 (https=)
DK (1) DK0974598T3 (https=)
ES (1) ES2372156T3 (https=)
PT (1) PT974598E (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69933897T2 (de) * 1998-12-10 2007-03-15 Pfizer Products Inc., Groton Carbamat- und Carbazatketolid-Antibiotika
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
WO2006035301A2 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Erythromycin a derivatives as antibacterial agents
US20090170790A1 (en) * 2004-10-25 2009-07-02 Biswajit Das Ketolide derivatives as antibacterial agents
UA85937C2 (uk) * 2004-12-21 2009-03-10 Пфайзер Продактс Інк. Макроліди
EP1957085A2 (en) * 2005-11-08 2008-08-20 Ranbaxy Laboratories, Ltd. Macrolides as anti-inflammatory agents
US20090075916A1 (en) * 2005-11-23 2009-03-19 Upadhyay Dilip J Use of Macrolide Derivatives for Treating Acne
US20090005325A1 (en) * 2005-11-23 2009-01-01 Biswajit Bas Ketolide Derivatives as Antibacterial Agents
WO2007060618A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Macrolides derivatives as antibacterial agents
EP2102226B1 (en) * 2006-12-12 2012-08-22 ZAMBON S.p.A. Macrolide compounds endowed with antiinflammatory activity
AU2019403048B2 (en) * 2018-12-17 2025-01-23 Lunella Biotech, Inc. Triple combination therapies for targeting mitochondria and killing cancer stem cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) * 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
ATE259823T1 (de) * 1995-11-08 2004-03-15 Abbott Lab Tricyclische erythromycinderivate
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
DE69733422T2 (de) 1996-09-04 2006-05-04 Abbott Laboratories, Abbott Park 6-0-substituierte ketoliden mit antibakteriellen wirkung
BR9812577A (pt) * 1997-09-30 2000-10-17 Abbott Lab Composto, processo para preparar o mesmo, composição farmacêutica, e, processo para tratar infecções bacterianas

Also Published As

Publication number Publication date
ATE521619T1 (de) 2011-09-15
US6433151B1 (en) 2002-08-13
JP4573925B2 (ja) 2010-11-04
ES2372156T3 (es) 2012-01-16
EP0974598A2 (fr) 2000-01-26
DK0974598T3 (da) 2011-12-19
JP2000026494A (ja) 2000-01-25
EP0974598B1 (fr) 2011-08-24
PT974598E (pt) 2011-11-23
EP0974598A3 (fr) 2003-12-17

Similar Documents

Publication Publication Date Title
CY1112087T1 (el) Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
ES2085130T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion, y su aplicacion como medicamentos.
FR2518088B1 (fr) Nouveaux derives d'aminoacides, et leur application therapeutique
TR199902593T2 (xx) �kame edilmi� fenil t�revleri, bunlar�n haz�rlanmas� ve kullan�m�.
YU37098A (sh) Novi derivati eritromicina, postupci za njihovo pripremanje i njihova primena kao medikamenata
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
NO308848B1 (no) Kromanforbindelse og farmasøytisk preparat som inneholder den
DE69018908D1 (de) N-aryl und N-Heteroarylamide und Harnstoffderivate als Inhibitoren von Acyl-Coenzym A: Cholesterol-Acyl-Transferase.
SE8107537L (sv) Nya derivat av heterocykliska aminoalcoyler, deras framstellningssett och deras terapeutiska anvendning
SE8502017D0 (sv) 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
EA200100983A1 (ru) Производные 13-метилэритромицина
ATE169637T1 (de) Derivate des dolastatin
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
DK0424194T3 (da) Benzanilider
ECSP941031A (es) Derivados de timosina alfa 1
TR199801196T2 (xx) Biyolojik aktif benzotiyazolon etanaminler.
NO994104L (no) 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler
SE8303913L (sv) Heterocykliska foreningar
EE02942B1 (et) Metüülpiperasinoasepiini derivaadid, nende valmistamine ja kasutamine
NO304314B1 (no) Cykloheksanderivater og anvendelse av forbindelsene for fremstilling av legemidler
DK0541322T3 (da) 1-Alkyl-2-acyl-1,2-disulfonylhydraziner med antineoplastisk aktivitet
OA07703A (fr) Polyméthylène imines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
PT90601A (pt) Processo para a preparacao de composicoes farmaceuticas com base em derivados de pirimido-(6,1-a)-isoquinolina-4-onas